Guatemala + 4 more

First doses donated by Spain through COVAX arrive to Peru, Guatemala, Paraguay and Nicaragua

Format
News and Press Release
Source
Posted
Originally published
Origin
View original

As part of its pledge to deliver 22.5 million doses of COVID-19 vaccines, the first doses donated by Spain are arriving to countries in Latin America

Pedro Sánchez Pérez-Castejón, President of the Government of Spain: “We will only be safe from the virus when everyone on the planet is safe. We have committed to donate over 22 million vaccines to COVAX and are proud to see them being delivered to those who need them the most.”

Dr Seth Berkley, CEO, Gavi, the Vaccine Alliance: “Since the outbreak of the pandemic, the Government of Spain has been a strong supporter of COVAX having pledged both substantial funding and vaccine doses. We are thankful to Spain for sharing the responsibility of ending the acute stage of the pandemic through the conversion of these pledges into deliveries.”

Geneva, 5 August 2021 – The first deliveries from a pledge of 22.5 million doses to be donated to COVAX by Spain are arriving today, with 101,760 doses of AstraZeneca (AZ) vaccine to Peru, 201,600 doses to Guatemala and 253, 440 doses to Paraguay, followed by 97,920 doses to Nicaragua on 6 August. This marks the first deliveries of doses donated by an EU Member State through COVAX to Latin American countries. Spain is donating doses to COVAX on top of the USD 122 million it has pledged to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC).

This donation by Spain allows COVAX to deliver more vaccines in the third quarter of this year, before supply from COVAX purchase agreements increases in Q4, meaning that more people will be able to access vaccines now, at a time when variants are a major threat to global health and stability.

“Sharing doses with COVAX now represents the single most effective intervention a country can make in terms of keeping the pandemic in check,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, which leads on procurement and delivery at scale for COVAX. “These deliveries to countries enable COVAX to reach some of those in need of protection, and we are grateful to the Spanish government and the Spanish people for their continued support.”

“We still need to improve global equitable access to vaccines which means international collective actions are required to finance and secure the doses needed in order to leave no one behind. We remain committed to protect those suffering the most during the pandemic,” said Pedro Sánchez Pérez-Castejón, President of the Government of Spain.

These doses donated by Spain are produced by the AstraZeneca manufacturing network. Donating through COVAX helps to increase vaccine coverage, ensures that no dose goes to waste, and helps to bring an end to the acute phase of the pandemic. The design and operationalization of the COVAX dose sharing mechanism is being supported by a contribution of CAD 5 million from Canada.

The donation of doses via COVAX are enabled via tripartite agreements between Gavi, manufacturers, and donating countries. The shipments to countries will be enabled by COVAX delivery partners UNICEF and the Pan American Health Organisation (PAHO).

Over 600 million doses have already been pledged to COVAX by a number of countries in response to short-term supply challenges and the rise of new variants. Working with donor governments to operationalise growing numbers of dose-sharing pledges, COVAX expects to see more deliveries of donated doses in the weeks and months to come.

Notes to editors

About COVAX

COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, is co-led by CEPI, Gavi and WHO – working in partnership with developed and developing country vaccine manufacturers, UNICEF, PAHO, the World Bank, and others. It is the only global initiative that is working with governments and manufacturers to ensure COVID-19 vaccines are available worldwide to both high-income and lower-income countries.

Gavi’s role in COVAX

Gavi leads on procurement and delivery at scale for COVAX: designing and managing the COVAX Facility and the Gavi COVAX AMC and working with its traditional Alliance partners UNICEF and WHO, along with governments, on country readiness and delivery. As part of this role, Gavi hosts the Office of the COVAX Facility to coordinate the operation and governance of the mechanism as a whole, holds financial and legal relationships with 193 Facility participants, and manages the COVAX Facility deals portfolio: negotiating advance purchase agreements with manufacturers of promising vaccine candidates to secure doses on behalf of all COVAX Facility participants. Gavi also coordinates design, operationalisation and fundraising for the Gavi COVAX AMC, the mechanism that provides access to donor-funded doses of vaccine to 92 lower-income economies. As part of this work, Gavi provides funding and oversight for UNICEF procurement and delivery of vaccines to all AMC participants – operationalising the advance purchase agreements between Gavi and manufacturers – as well as support for partners’ and governments work on readiness and delivery. This includes tailored support to governments, UNICEF, WHO and other partners for cold chain equipment, technical assistance, syringes, vehicles, and other aspects of the vastly complex logistical operation for delivery. Gavi also co-designed, raises funds for and supports the operationalisation of the AMC’s no-fault compensation mechanism as well as the COVAX Humanitarian Buffer.

About Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 822 million children – and prevented more than 14 million deaths, helping to halve child mortality in 73 lower-income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Facebook and Twitter.

The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organizations that fund Gavi’s work here.

MEDIA CONTACTS

Meg Sharafudeen
+41 79 711 55 54
msharafudeen@gavi.org

Iryna Mazur
+41 79 429 3671
imazur@gavi.org

Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org